Back to Insider Trading View Full Company Profile

RAPP

MODERATE

Rapport Therapeutics, Inc.

CIK: 0002012593

Strong Sell (90% confidence)

Last activity: 3 weeks ago

Financial Metrics

As of Dec 31, 2024 (10-K)

Net Income -$78.31M

Insider Roster (4 total, 4 active)

Insider Buys Sells Net Value Holdings
Bredt David
Chief Scientific Officer
0 5 -$681K
395,775 shares
$10.62M
Ceesay Abraham
Chief Executive Officer
0 8 -$609K
562,080 shares
$14.68M
Gault Cheryl
Chief Operating Officer
0 1 -$150K
171,928 shares
$5.17M
Yeleswaram Krishnaswamy
Chief Development Officer
0 1 -$85K
296,991 shares
$8.92M

Recent Transactions

SELL Ceesay Abraham (Chief Executive Officer)

5,833 shares @ $26.12

$152K

Jan 20, 2026

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

5,083 shares @ $26.11

$133K

Jan 20, 2026

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

8,300 shares @ $26.83

$223K

Jan 15, 2026

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

200 shares @ $27.40

$5K

Jan 15, 2026

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

6,567 shares @ $30.05

$197K

Dec 31, 2025

Conviction: | View SEC Filing →
SELL Yeleswaram Krishnaswamy (Chief Development Officer)

2,840 shares @ $30.05

$85K

Dec 31, 2025

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

2,792 shares @ $30.04

$84K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

2,421 shares @ $30.04

$73K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

2,441 shares @ $28.84

$70K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

2,147 shares @ $28.84

$62K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

600 shares @ $31.04

$19K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

515 shares @ $31.04

$16K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

7,704 shares @ $29.95

$231K

Dec 15, 2025

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

796 shares @ $30.68

$24K

Dec 15, 2025

Conviction: | View SEC Filing →
SELL Gault Cheryl (Chief Operating Officer)

5,000 shares @ $30.10

$150K

Nov 26, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.